Keyphrases
Colorectal Cancer
100%
Stereotactic Radiosurgery
92%
Tumor
54%
Gamma Knife Radiosurgery
49%
Gastric Cancer
48%
Colorectal Cancer Patients
44%
Overall Survival
42%
Taiwan
35%
Metastatic Colorectal Cancer (mCRC)
34%
Brain Metastases
32%
Radiosurgery
31%
Arteriovenous Malformation
28%
Gastric Cancer Patients
27%
Prognostic Factors
27%
Multivariate Analysis
23%
Microsatellite Instability-high (MSI-H)
22%
Curative Surgery
20%
Lymph Node Metastasis
20%
Chemotherapy
20%
Carcinoembryonic Antigen
20%
Taipei
20%
5-year Survival
20%
International multicenter Study
19%
Brain Arteriovenous Malformation (bAVM)
19%
Overexpression
18%
General Hospital
18%
Colon Cancer
18%
Disease-free Survival
17%
Resection
17%
Non-small Cell Lung Cancer (NSCLC)
16%
Confidence Interval
15%
Patients with Colorectal Cancer
15%
Cerebral Arteriovenous Malformation
15%
5-fluorouracil (5-FU)
14%
Independent Prognostic Factor
14%
Hazard Ratio
14%
Curative Resection
14%
Poor Prognosis
13%
Carcinoembryonic Antigen Levels
13%
Risk Factors
13%
Obliteration
13%
Clinical Significance
13%
Magnetic Resonance Imaging
12%
Carcinoma
12%
Surgical Outcomes
12%
Prognostic Value
12%
National Cohort Study
12%
Clinical Papers
12%
Tumor Size
11%
Distant Metastasis
11%
Colorectal Cancer Cells
11%
Genetic Modification
11%
Vestibular Schwannoma
11%
Gastric Carcinoma
11%
Dural Arteriovenous Fistula (dAVF)
11%
Tumor Volume
11%
Completely Resected
11%
Lung Adenocarcinoma
11%
Gastric Adenocarcinoma
11%
Clinical Outcomes
10%
Stomach
10%
Metastasis
10%
Tumor Recurrence
10%
Liver Metastasis
10%
High Risk
9%
Leucovorin
9%
Prognostic Significance
9%
Surgical Resection
9%
Lymphovascular Invasion
9%
Colon Cancer Cells
9%
Patient Survival
9%
Oxaliplatin
9%
Tumor Cells
8%
Tumor Control
8%
Univariate Analysis
8%
Meningioma
8%
After Surgery
8%
Survival Rate
8%
Right-sided Colon Cancer
8%
Progression-free Survival
8%
Colorectal Carcinoma
8%
Multi-institutional Study
8%
Prognostic Indicator
7%
Treatment Outcome
7%
Digital Subtraction Angiography
7%
Polymorphism
7%
Young Patients
7%
Overall Survival Rate
7%
Gastrectomy
7%
Odds Ratio
7%
Local Tumor Control
7%
Mortality Rate
7%
Embolization
7%
Intracranial Dural Arteriovenous Fistula
7%
BRAF mutation
6%
Taiwanese
6%
KRAS mutation
6%
FOLFOX
6%
Hypermethylation
6%
Adjuvant Chemotherapy
6%
Medicine and Dentistry
Neoplasm
94%
Colorectal Carcinoma
88%
Stereotactic Radiosurgery
83%
Abdominal Cancer
63%
Surgery
52%
Overall Survival
45%
Recurrent Disease
39%
Prognostic Factor
33%
Disease
29%
Arteriovenous Malformation
29%
Metastatic Carcinoma
29%
Radiosurgery
28%
Brain Metastasis
28%
Gamma Knife Radiosurgery
25%
Colon Carcinoma
25%
Bleeding
24%
Gastrectomy
22%
Lymph Node Metastasis
22%
Rectum Cancer
22%
Malignant Neoplasm
22%
Survival Rate
21%
Cohort Analysis
21%
Cerebral Arteriovenous Malformation
19%
Carcinoembryonic Antigen
18%
Chemotherapy
18%
Disease Free Survival
16%
Multivariate Analysis
16%
Lung Cancer
16%
Dural Arteriovenous Fistula
15%
Lymph Node
15%
Non Small Cell Lung Cancer
14%
Lung Adenocarcinoma
12%
Hazard Ratio
11%
Breast Cancer
11%
Carcinoma
11%
Liver Metastasis
11%
Gene Mutation
11%
Cancer Cell
11%
Retrospective Study
10%
Laparoscopic Surgery
10%
Proportional Hazards Model
9%
Meningioma
9%
Chemoradiotherapy
9%
Free Tissue Graft
9%
Magnetic Resonance Imaging
9%
Microsatellite Instability
8%
Stomach Carcinoma
8%
Embolization
8%
Distant Metastasis
8%
Stomach Adenocarcinoma
8%
Radiation Therapy
8%
Metastasectomy
8%
Adenocarcinoma
8%
Metastatic Colorectal Cancer
8%
Lymphovascular Invasion
8%
Carcinogenesis
7%
Tumor Recurrence
7%
Retroperitoneal Lymph Node Dissection
7%
Progression Free Survival
7%
Primary Tumor
7%
Cancer Growth
7%
Mortality Rate
7%
In Vitro
7%
Univariate Analysis
7%
Cavernous Sinus
6%
Tumor Cell
6%
Tumor Progression
6%
Randomized Controlled Trial
6%
Retrospective Cohort Study
6%
Epidermal Growth Factor Receptor
6%
Pneumonectomy
6%
Colorectal Surgery
6%
Cancer
6%
Quality of Life
6%
Odds Ratio
6%
Biological Marker
6%
Colon
5%
Squamous Cell Carcinoma
5%
Vestibular Schwannoma
5%
Radiation Necrosis
5%
Fasciocutaneous Flap
5%
Surgeon
5%
Adjuvant Chemotherapy
5%
Operation Duration
5%
Cancer Surgery
5%
Total Mesorectal Excision
5%
Radiation Response
5%
Digital Subtraction Angiography
5%
Fluorouracil
5%
Anastomosis Leakage
5%